MICHELLE NOLASCO: Open Payments
NPI 1215633219 · WOODBRIDGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$299 in 15 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $299
Food & beverage: $299
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| Exact Sciences Corporation | 3 | $80 |
| Novo Nordisk Inc | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Lilly USA, LLC | 2 | $31 |
| Astellas Pharma US Inc | 1 | $19 |
| Dexcom, Inc. | 1 | $17 |
Products named: Kerendia, The Cologuard Plus Collection Kit, Ozempic, BREZTRI, Veozah, Dexcom G6 Transmitter, JARDIANCE, FARXIGA.
Industry payments across NJ — which companies pay providers there.
